← Back to Search

Behavioral Intervention

Virtual Music Therapy for Alzheimer's Disease

N/A
Recruiting
Led By Alexander Pantelyat, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-89
Mild Cognitive Impairment (MoCA score: 18-25) or Early AD (MoCA score: 17-24)
Must not have
Head trauma, traumatic brain injury, or concussion with loss of consciousness for >2 minutes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1, day 3, day 8, day 10, day 15, day 17, day 22, day 24, day 29, day 31, day 36, day 38, day 43, day 45, day 50, day 52
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess if reminiscence-based virtual music therapy can help people with MCI or mild dementia due to AD by enhancing their autobiographical memory, mood, and cognition.

Who is the study for?
This trial is for adults aged 18-89 with mild cognitive impairment or early Alzheimer's Disease, as indicated by specific scores on a cognitive assessment test (MoCA). It excludes those who've had significant head trauma, are claustrophobic to the extent that they can't undergo MRI scans, have medical devices or metal in their body that interfere with MRI technology.
What is being tested?
The study tests if virtual music therapy sessions focused on reminiscence can improve memory, mood, and thinking abilities in patients. Participants will attend two sessions per week over eight weeks. Their self-reported feelings and objective measures of cognition will be evaluated before and after treatment using fMRI imaging.
What are the potential side effects?
Since this trial involves non-invasive music therapy, there are no direct physical side effects expected from the intervention itself. However, participants may experience varying emotional responses to the therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 89 years old.
Select...
My memory test score indicates mild cognitive issues or early Alzheimer's.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a head injury with unconsciousness for more than 2 minutes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1, day 3, day 8, day 10, day 15, day 17, day 22, day 24, day 29, day 31, day 36, day 38, day 43, day 45, day 50, day 52
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1, day 3, day 8, day 10, day 15, day 17, day 22, day 24, day 29, day 31, day 36, day 38, day 43, day 45, day 50, day 52 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in autobiographical memory level as assessed by Autobiographical Memory Test (AMT)
Change in scores on neuropsychiatric symptom level as assessed by Neuropsychiatric Inventory Questionnaire (NPI-Q) (caregivers)
Secondary study objectives
Change in anxiety level as assessed by State-Trait Anxiety Inventory (STAI)
Change in cognition as assessed by the Montreal Cognitive Assessment (MoCA)
Change in cortical activation as assessed by Blood Oxygen Level Dependent (BOLD) on functional magnetic resonance imaging (fMRI)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual Music TherapyExperimental Treatment1 Intervention
Participants will attend two 30 minutes long virtual music therapy sessions per week for 8 weeks using Zoom.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,327 Previous Clinical Trials
14,874,750 Total Patients Enrolled
Alexander Pantelyat, MDPrincipal InvestigatorDepartment of Neurology, Johns Hopkins School of Medicine
6 Previous Clinical Trials
116 Total Patients Enrolled

Media Library

Virtual Music Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05151562 — N/A
Alzheimer's Disease Research Study Groups: Virtual Music Therapy
Alzheimer's Disease Clinical Trial 2023: Virtual Music Therapy Highlights & Side Effects. Trial Name: NCT05151562 — N/A
Virtual Music Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05151562 — N/A
~22 spots leftby Apr 2026